NASDAQ:VRTX
Vertex Pharmaceuticals Incorporated
- Stock
$
Share Trends
Recent Transactions
| Reporter | Filed at | Change (shares) |
|---|---|---|
| Tatsis Ourania EVP, Chief Reg. & Quality Off. Common Stock | 2023-02-28 | -3.662K -6.06% |
| Sachdev Amit EVP, Chief Patient Officer Common Stock | 2023-02-28 | -2.468K -3.58% |
| Wagner Charles F Jr EVP & Chief Financial Officer Common Stock | 2023-02-28 | -3.308K -5.38% |
| Leiden Jeffrey M Executive Chairman Common Stock | 2023-02-28 | -13.73K -22.12% |
| Kewalramani Reshma CEO & President Common Stock | 2023-02-28 | -9.386K -6.74% |
Largest Transactions
| Reporter | Filed at | Change (shares) |
|---|---|---|
| Leiden Jeffrey M CEO & President Common Stock | 2019-02-08 | 113.8K 91.10% |
| Leiden Jeffrey M CEO & President Common Stock | 2019-02-13 | -111.4K -46.70% |
| Leiden Jeffrey M CEO & President Common Stock | 2020-02-07 | 110.5K 103.88% |
| Leiden Jeffrey M Executive Chairman Common Stock | 2021-02-05 | 75.29K 3,257.85% |
| Leiden Jeffrey M Executive Chairman Common Stock | 2022-07-27 | -71.74K -96.73% |
Transaction Log
| Reporter | Filing Date | Transaction Date | Title | T | Stock Class | price | USD | Quantity | Post Shares | delta |
|---|---|---|---|---|---|---|---|---|---|---|
| Tatsis Ourania | 2023-02-28 | 2023-02-27 | EVP, Chief Reg. & Quality Off. | S | Common Stock | 287.20 | -81.28K | 283.00 | 56.88K | 0.00 |
| Leiden Jeffrey M | 2023-02-28 | 2023-02-24 | Executive Chairman | F | Common Stock | 289.12 | -3.97M | 13.73K | 48.35K | -0.22 |
| Sachdev Amit | 2023-02-28 | 2023-02-24 | EVP, Chief Patient Officer | F | Common Stock | 289.12 | -713.5K | 2.468K | 66.52K | -0.04 |
| Wagner Charles F Jr | 2023-02-28 | 2023-02-24 | EVP & Chief Financial Officer | F | Common Stock | 289.12 | -956.4K | 3.308K | 58.13K | -0.05 |
| Tatsis Ourania | 2023-02-28 | 2023-02-24 | EVP, Chief Reg. & Quality Off. | F | Common Stock | 289.12 | -956.4K | 3.308K | 57.16K | -0.05 |
| Sanna Bastiano | 2023-02-28 | 2023-02-24 | EVP, Cell & Genetic Therapies | F | Common Stock | 289.12 | -1.148M | 3.97K | 52.01K | -0.07 |
| Tatsis Ourania | 2023-02-28 | 2023-02-27 | EVP, Chief Reg. & Quality Off. | S | Common Stock | 289.29 | -5.786K | 20.00 | 56.81K | 0.00 |
| Kewalramani Reshma | 2023-02-28 | 2023-02-24 | CEO & President | F | Common Stock | 289.12 | -2.714M | 9.386K | 130K | -0.07 |
| Tatsis Ourania | 2023-02-28 | 2023-02-27 | EVP, Chief Reg. & Quality Off. | S | Common Stock | 288.33 | -14.7K | 51.00 | 56.83K | 0.00 |
| Arbuckle Stuart A | 2023-02-24 | 2023-02-22 | EVP, COO | S | Common Stock | 295.38 | -116.4K | 394.00 | 66.5K | -0.01 |
| Arbuckle Stuart A | 2023-02-24 | 2023-02-22 | EVP, COO | S | Common Stock | 291.84 | -37.65K | 129.00 | 68.58K | 0.00 |
| Arbuckle Stuart A | 2023-02-24 | 2023-02-22 | EVP, COO | S | Common Stock | 296.31 | -59.26K | 200.00 | 66.3K | 0.00 |
| Arbuckle Stuart A | 2023-02-24 | 2023-02-22 | EVP, COO | S | Common Stock | 292.86 | -87.86K | 300.00 | 68.28K | 0.00 |
| Arbuckle Stuart A | 2023-02-24 | 2023-02-22 | EVP, COO | S | Common Stock | 294.29 | -405.5K | 1.378K | 66.9K | -0.02 |
| Arbuckle Stuart A | 2023-02-16 | 2023-02-14 | EVP, COO | S | Common Stock | 300.09 | -520.4K | 1.734K | 76.01K | -0.02 |
| Altshuler David | 2023-02-16 | 2023-02-14 | EVP, Global Research and CSO | S | Common Stock | 296.85 | -249.9K | 842.00 | 52.75K | -0.02 |
| Altshuler David | 2023-02-16 | 2023-02-14 | EVP, Global Research and CSO | S | Common Stock | 300.11 | -566.6K | 1.888K | 48.31K | -0.04 |
| Altshuler David | 2023-02-16 | 2023-02-14 | EVP, Global Research and CSO | S | Common Stock | 295.79 | -236.6K | 800.00 | 53.6K | -0.01 |
| Tatsis Ourania | 2023-02-16 | 2023-02-14 | EVP, Chief Reg. & Quality Off. | S | Common Stock | 299.60 | -40.45K | 135.00 | 65.5K | 0.00 |
| Tatsis Ourania | 2023-02-16 | 2023-02-14 | EVP, Chief Reg. & Quality Off. | S | Common Stock | 297.98 | -12.81K | 43.00 | 65.63K | 0.00 |
| Altshuler David | 2023-02-16 | 2023-02-14 | EVP, Global Research and CSO | S | Common Stock | 297.97 | -117.7K | 395.00 | 52.36K | -0.01 |
| Tatsis Ourania | 2023-02-16 | 2023-02-14 | EVP, Chief Reg. & Quality Off. | S | Common Stock | 296.48 | -5.93K | 20.00 | 65.67K | 0.00 |
| Arbuckle Stuart A | 2023-02-16 | 2023-02-14 | EVP, COO | S | Common Stock | 295.84 | -236.7K | 800.00 | 81.2K | -0.01 |
| Arbuckle Stuart A | 2023-02-16 | 2023-02-14 | EVP, COO | S | Common Stock | 298.14 | -167K | 560.00 | 79.74K | -0.01 |
| Altshuler David | 2023-02-16 | 2023-02-14 | EVP, Global Research and CSO | S | Common Stock | 299.08 | -647.5K | 2.165K | 50.19K | -0.04 |
| Arbuckle Stuart A | 2023-02-16 | 2023-02-14 | EVP, COO | S | Common Stock | 296.85 | -267.5K | 901.00 | 80.3K | -0.01 |
| Arbuckle Stuart A | 2023-02-16 | 2023-02-14 | EVP, COO | S | Common Stock | 300.89 | -120.4K | 400.00 | 75.61K | -0.01 |
| Tatsis Ourania | 2023-02-16 | 2023-02-14 | EVP, Chief Reg. & Quality Off. | S | Common Stock | 300.58 | -15.33K | 51.00 | 65.45K | 0.00 |
| Sanna Bastiano | 2023-02-16 | 2023-02-14 | EVP, Cell & Genetic Therapies | S | Common Stock | 301.11 | -84.01K | 279.00 | 59.73K | 0.00 |
| Sanna Bastiano | 2023-02-16 | 2023-02-14 | EVP, Cell & Genetic Therapies | S | Common Stock | 300.29 | -571.2K | 1.902K | 60.01K | -0.03 |
| Altshuler David | 2023-02-16 | 2023-02-14 | EVP, Global Research and CSO | S | Common Stock | 301.02 | -92.71K | 308.00 | 48K | -0.01 |
| Tatsis Ourania | 2023-02-16 | 2023-02-14 | EVP, Chief Reg. & Quality Off. | S | Common Stock | 295.89 | -21.01K | 71.00 | 65.69K | 0.00 |
| Arbuckle Stuart A | 2023-02-16 | 2023-02-14 | EVP, COO | S | Common Stock | 299.13 | -599.2K | 2.003K | 77.74K | -0.03 |
| Sachs Bruce I | 2023-02-02 | 2023-01-31 | Director | S | Common Stock | 325.01 | -390K | 1.2K | 41.21K | -0.03 |
| Sachs Bruce I | 2023-02-02 | 2023-01-31 | Director | M | Common Stock | 72.14 | 86.57K | 1.2K | 42.41K | 0.03 |
| Sanna Bastiano | 2023-02-02 | 2023-01-31 | EVP, Cell & Genetic Therapies | S | Common Stock | 325.00 | -34.45K | 106.00 | 38K | 0.00 |
| Lee Yuchun | 2023-01-31 | 2023-01-27 | Director | M | Common Stock | 72.14 | 103.1K | 1.429K | 3.304K | 0.76 |
| Carney Lloyd | 2023-01-31 | 2023-01-30 | Director | S | Common Stock | 320.70 | -320.7K | 1K | 4.474K | -0.18 |
| Lee Yuchun | 2023-01-31 | 2023-01-27 | Director | S | Common Stock | 322.20 | -312.5K | 970.00 | 1.955K | -0.33 |
| Lee Yuchun | 2023-01-31 | 2023-01-27 | Director | S | Common Stock | 321.31 | -121.8K | 379.00 | 2.925K | -0.11 |
| Lee Yuchun | 2023-01-31 | 2023-01-27 | Director | S | Common Stock | 323.33 | -25.87K | 80.00 | 1.875K | -0.04 |
| Carney Lloyd | 2023-01-31 | 2023-01-30 | Director | S | Common Stock | 321.84 | -104.3K | 324.00 | 4.15K | -0.07 |
| Carney Lloyd | 2023-01-31 | 2023-01-30 | Director | S | Common Stock | 320.08 | -440.4K | 1.376K | 5.474K | -0.20 |
| Lee Yuchun | 2023-01-19 | 2023-01-17 | Director | S | Common Stock | 312.03 | -1.248M | 4K | 1.875K | -0.68 |
| Lee Yuchun | 2023-01-19 | 2023-01-17 | Director | M | Common Stock | 72.14 | 288.6K | 4K | 5.875K | 2.13 |
| Lee Yuchun | 2023-01-19 | 2023-01-18 | Director | M | Common Stock | 72.14 | 31.89K | 442.00 | 2.317K | 0.24 |
| Lee Yuchun | 2023-01-19 | 2023-01-18 | Director | S | Common Stock | 312.17 | -138K | 442.00 | 1.875K | -0.19 |
| Altshuler David | 2022-11-09 | 2022-11-07 | EVP, Global Research and CSO | S | Common Stock | 300.96 | -63.2K | 210.00 | 37.03K | -0.01 |
| Altshuler David | 2022-11-09 | 2022-11-07 | EVP, Global Research and CSO | S | Common Stock | 301.99 | -57.08K | 189.00 | 36.84K | -0.01 |
| Altshuler David | 2022-11-09 | 2022-11-07 | EVP, Global Research and CSO | S | Common Stock | 304.58 | -85.28K | 280.00 | 36.3K | -0.01 |
| Altshuler David | 2022-11-09 | 2022-11-07 | EVP, Global Research and CSO | S | Common Stock | 299.72 | -41.96K | 140.00 | 37.24K | 0.00 |
| Altshuler David | 2022-11-09 | 2022-11-07 | EVP, Global Research and CSO | S | Common Stock | 305.39 | -42.75K | 140.00 | 36.16K | 0.00 |
| Altshuler David | 2022-11-09 | 2022-11-07 | EVP, Global Research and CSO | S | Common Stock | 306.57 | -25.45K | 83.00 | 36.08K | 0.00 |
| Altshuler David | 2022-11-09 | 2022-11-07 | EVP, Global Research and CSO | S | Common Stock | 303.21 | -79.14K | 261.00 | 36.58K | -0.01 |
| Altshuler David | 2022-11-09 | 2022-11-07 | EVP, Global Research and CSO | M | Common Stock | 187.53 | 244.4K | 1.303K | 37.38K | 0.04 |
| Sanna Bastiano | 2022-11-03 | 2022-11-02 | EVP, Cell & Genetic Therapies | S | Common Stock | 312.40 | -31.24K | 100.00 | 38.23K | 0.00 |
| Sanna Bastiano | 2022-11-03 | 2022-11-02 | EVP, Cell & Genetic Therapies | S | Common Stock | 313.37 | -25.38K | 81.00 | 38.15K | 0.00 |
| Sanna Bastiano | 2022-11-03 | 2022-11-02 | EVP, Cell & Genetic Therapies | S | Common Stock | 314.43 | -3.773K | 12.00 | 38.14K | 0.00 |
| Sanna Bastiano | 2022-11-03 | 2022-11-02 | EVP, Cell & Genetic Therapies | S | Common Stock | 315.68 | -3.157K | 10.00 | 38.13K | 0.00 |
| Sanna Bastiano | 2022-11-03 | 2022-11-02 | EVP, Cell & Genetic Therapies | S | Common Stock | 310.10 | -17.37K | 56.00 | 38.37K | 0.00 |
| Sanna Bastiano | 2022-11-03 | 2022-11-02 | EVP, Cell & Genetic Therapies | S | Common Stock | 311.17 | -12.14K | 39.00 | 38.33K | 0.00 |
| Sanna Bastiano | 2022-11-03 | 2022-11-02 | EVP, Cell & Genetic Therapies | S | Common Stock | 317.77 | -6.991K | 22.00 | 38.1K | 0.00 |
| Sanna Bastiano | 2022-11-03 | 2022-11-01 | EVP, Cell & Genetic Therapies | F | Common Stock | 312.84 | -240.3K | 768.00 | 38.42K | -0.02 |
| Bhatia Sangeeta N. | 2022-10-26 | 2022-10-24 | Director | S | Common Stock | 310.00 | -192.5K | 621.00 | 4.04K | -0.13 |
| Sanna Bastiano | 2022-10-20 | 2022-10-18 | EVP, Cell & Genetic Therapies | S | Common Stock | 300.02 | -450.9K | 1.503K | 39.48K | -0.04 |
| Sanna Bastiano | 2022-10-20 | 2022-10-18 | EVP, Cell & Genetic Therapies | S | Common Stock | 301.84 | -86.93K | 288.00 | 39.19K | -0.01 |
| Biller Jonathan | 2022-09-21 | 2022-09-19 | EVP and Chief Legal Officer | A | Common Stock | - | 0 | 5.294K | 5.294K | 1.00 |
| Arbuckle Stuart A | 2022-08-17 | 2022-08-15 | EVP, COO | S | Common Stock | 305.38 | -2.122M | 6.948K | 45.28K | -0.13 |
| Arbuckle Stuart A | 2022-08-17 | 2022-08-15 | EVP, COO | S | Common Stock | 302.55 | -121K | 400.00 | 61.56K | -0.01 |
| Arbuckle Stuart A | 2022-08-17 | 2022-08-15 | EVP, COO | S | Common Stock | 303.78 | -710.5K | 2.339K | 59.22K | -0.04 |
| Kewalramani Reshma | 2022-08-17 | 2022-08-15 | CEO & President | S | Common Stock | 305.06 | -3.566M | 11.69K | 99.6K | -0.11 |
| Arbuckle Stuart A | 2022-08-17 | 2022-08-15 | EVP, COO | S | Common Stock | 304.67 | -2.13M | 6.99K | 52.23K | -0.12 |
| Liu Joy | 2022-08-17 | 2022-08-15 | SVP, General Counsel | S | Common Stock | 305.57 | -91.67K | 300.00 | 9.605K | -0.03 |
| Arbuckle Stuart A | 2022-08-17 | 2022-08-15 | EVP, COO | S | Common Stock | 301.61 | -1.279M | 4.242K | 61.96K | -0.06 |
| Liu Joy | 2022-08-17 | 2022-08-15 | SVP, General Counsel | S | Common Stock | 301.63 | -210.5K | 698.00 | 12.45K | -0.05 |
| Liu Joy | 2022-08-17 | 2022-08-15 | SVP, General Counsel | S | Common Stock | 302.35 | -30.24K | 100.00 | 12.35K | -0.01 |
| Liu Joy | 2022-08-17 | 2022-08-15 | SVP, General Counsel | S | Common Stock | 303.99 | -212.8K | 700.00 | 11.65K | -0.06 |
| Arbuckle Stuart A | 2022-08-17 | 2022-08-15 | EVP, COO | S | Common Stock | 300.30 | -376.6K | 1.254K | 66.2K | -0.02 |
| Arbuckle Stuart A | 2022-08-17 | 2022-08-15 | EVP, COO | M | Common Stock | 155.57 | 1.022M | 6.571K | 67.45K | 0.11 |
| Liu Joy | 2022-08-17 | 2022-08-15 | SVP, General Counsel | S | Common Stock | 300.26 | -61.85K | 206.00 | 13.15K | -0.02 |
| Liu Joy | 2022-08-17 | 2022-08-15 | SVP, General Counsel | S | Common Stock | 305.01 | -531.6K | 1.743K | 9.905K | -0.15 |
| Arbuckle Stuart A | 2022-08-12 | 2022-08-10 | EVP, COO | M | Common Stock | 155.57 | 9.956K | 64.00 | 61.06K | 0.00 |
| Arbuckle Stuart A | 2022-08-12 | 2022-08-10 | EVP, COO | S | Common Stock | 300.32 | -51.35K | 171.00 | 60.89K | 0.00 |
| Arbuckle Stuart A | 2022-08-12 | 2022-08-10 | EVP, COO | S | Common Stock | 302.01 | -2.718K | 9.00 | 60.88K | 0.00 |
| Liu Joy | 2022-08-12 | 2022-08-10 | SVP, General Counsel | S | Common Stock | 300.32 | -10.81K | 36.00 | 13.35K | 0.00 |
| Tatsis Ourania | 2022-08-10 | 2022-08-09 | EVP, Chief Reg. & Quality Off. | S | Common Stock | 297.54 | -86.88K | 292.00 | 47.2K | -0.01 |
| Tatsis Ourania | 2022-08-10 | 2022-08-09 | EVP, Chief Reg. & Quality Off. | S | Common Stock | 298.77 | -202.9K | 679.00 | 46.52K | -0.01 |
| Arbuckle Stuart A | 2022-08-10 | 2022-08-09 | EVP, COO | S | Common Stock | 301.42 | -271.3K | 900.00 | 61K | -0.01 |
| Tatsis Ourania | 2022-08-10 | 2022-08-09 | EVP, Chief Reg. & Quality Off. | S | Common Stock | 299.79 | -84.84K | 283.00 | 46.24K | -0.01 |
| Liu Joy | 2022-08-10 | 2022-08-09 | SVP, General Counsel | S | Common Stock | 300.00 | -283.8K | 946.00 | 13.39K | -0.07 |
| Tatsis Ourania | 2022-08-10 | 2022-08-09 | EVP, Chief Reg. & Quality Off. | S | Common Stock | 301.67 | -22.32K | 74.00 | 46.09K | 0.00 |
| Arbuckle Stuart A | 2022-08-10 | 2022-08-09 | EVP, COO | M | Common Stock | 155.57 | 299.6K | 1.926K | 66.69K | 0.03 |
| Tatsis Ourania | 2022-08-10 | 2022-08-09 | EVP, Chief Reg. & Quality Off. | S | Common Stock | 300.64 | -21.65K | 72.00 | 46.16K | 0.00 |
| Altshuler David | 2022-08-10 | 2022-08-08 | EVP, Global Research and CSO | S | Common Stock | 293.99 | -88.78K | 302.00 | 36.22K | -0.01 |
| Altshuler David | 2022-08-10 | 2022-08-08 | EVP, Global Research and CSO | S | Common Stock | 295.14 | -43.09K | 146.00 | 36.08K | 0.00 |
| Bhatia Sangeeta N. | 2022-08-10 | 2022-08-08 | Director | S | Common Stock | 294.24 | -47.37K | 161.00 | 4.708K | -0.03 |
| Bhatia Sangeeta N. | 2022-08-10 | 2022-08-08 | Director | S | Common Stock | 291.76 | -47.85K | 164.00 | 5.073K | -0.03 |
| Bhatia Sangeeta N. | 2022-08-10 | 2022-08-08 | Director | S | Common Stock | 295.53 | -13.89K | 47.00 | 4.661K | -0.01 |
| Bhatia Sangeeta N. | 2022-08-10 | 2022-08-08 | Director | S | Common Stock | 293.15 | -59.8K | 204.00 | 4.869K | -0.04 |
| Altshuler David | 2022-08-10 | 2022-08-08 | EVP, Global Research and CSO | S | Common Stock | 291.53 | -123.6K | 424.00 | 36.74K | -0.01 |